Risk factors are things that raise your chances of getting a disease. For each person, there’s a mix of genetic, biological and lifestyle factors that play a part in prostate cancer risk. About 1 in ...

About 1 in 8 men will be diagnosed with prostate cancer during their lifetime, and 1 in 44 will die of the disease, according to the American Cancer Society (ACS). Fortunately, prostate cancer is ...

Prostate cancer is one of the most common and serious health issues affecting men worldwide. In its early stages, the symptoms are often subtle or easily overlooked — making early detection ...

Getty Images The American Cancer Society recommends that Black men discuss screening with their health care providers at age 45; the Prostate Cancer Foundation recommends prostate-specific antigen ...

Researchers at City of Hope ®, one of the largest and most advanced cancer research and treatment organizations in the United States, ranked among the nation's top 5 cancer centers by U.S. News & ...

IOWA CITY, Iowa (KWQC) -Prostate cancer remains the most common non-skin cancer in men and the second deadliest after lung cancer, according to the American Association of Cancer Research. As part of ...

Jyong Biotech develops plant-derived carotenoid drugs targeting BPH/LUTS with MCS-2 and prostate cancer prevention. The main asset is MCS-2, but they also have MCS-8 and IC in earlier clinical stages.

Prostate cancer (PC) is considered the second most prevalent cancer worldwide after lung cancer, with more than 1,414,259 new cases diagnosed in 2020 1. Over the years, Lebanon was considered one of ...

Prostate cancer is the second most commonly diagnosed cancer worldwide. Prostate biopsy, essential for definitive diagnosis, has evolved significantly with new technologies and techniques. Transrectal ...